GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sysmex Corp (TSE:6869) » Definitions » Debt-to-Revenue

Sysmex (TSE:6869) Debt-to-Revenue : 0.11 (As of Sep. 2024)


View and export this data going back to 1996. Start your Free Trial

What is Sysmex Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

Sysmex's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was 円8,362 Mil. Sysmex's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was 円47,314 Mil. Sysmex's annualized Revenue for the quarter that ended in Sep. 2024 was 円522,132 Mil. Sysmex's annualized Debt-to-Revenue for the quarter that ended in Sep. 2024 was 0.11.


Sysmex Debt-to-Revenue Historical Data

The historical data trend for Sysmex's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sysmex Debt-to-Revenue Chart

Sysmex Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Debt-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.08 0.07 0.06 0.06 0.12

Sysmex Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Debt-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.06 0.11 0.10 - 0.11

Competitive Comparison of Sysmex's Debt-to-Revenue

For the Medical Instruments & Supplies subindustry, Sysmex's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sysmex's Debt-to-Revenue Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Sysmex's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where Sysmex's Debt-to-Revenue falls into.



Sysmex Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

Sysmex's Debt-to-Revenue for the fiscal year that ended in Mar. 2024 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(8659 + 46680) / 461510
=0.12

Sysmex's annualized Debt-to-Revenue for the quarter that ended in Sep. 2024 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(8362 + 47314) / 522132
=0.11

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is four times the quarterly (Sep. 2024) Revenue data.


Sysmex Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of Sysmex's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Sysmex Business Description

Traded in Other Exchanges
Address
1-5-1 Wakinohara-Kaigandori, Chuo-ku, Hyogo Prefecture, Kobe, JPN, 6510073
Sysmex Corp manufactures and distributes in vitro diagnostic instruments, reagents, and software. The vast majority of the firm's revenue comes from selling tests for human bodily fluids to hospitals and commercial laboratories. Within this industry, the firm specializes in hematology reagents and instruments. Sysmex also sells in vitro diagnostics for applications like urinalysis and hemostasis and provides support and maintenance services for its systems. Over half of the firm's revenue is generated by sales of reagents and services, which are recurring sources of income. Sysmex primarily sells its products to customers in Japan, Europe, the Middle East, and Africa, and the Americas.

Sysmex Headlines

No Headlines